October 14, 2019 News Magazine

With a fresh $10 million in the bank, DotLab hopes to bring endometriosis test to market

Thirty-three-year-old founder of personalized medicine company DotLab, Heather Bowerman, wants to shake up the women’s health industry with what she believes to be a better, cheaper, less painful test for endometriosis.

Her company has just completed a Yale University -led validation study and raised $10 million in Series A funding from CooperSurgical, TigerGlobal Management, Luxor Capital Group and the law firm Wilson Sonsini Goodrich & Rosati to bring a new, non-invasive diagnostic test to market.

DotEndo

Endometriosis is an often painful disorder in which tissue begins to grow outside of the uterus and into a woman’s ovaries, fallopian tubes and pelvis. The disease may affect up to one in 10 women of childbearing years and about half of all women who experience infertility, according to the U.S. Department of Health and Human Services.

However, even with clear symptoms of the disease, doctors often try to test for endometriosis as a last resort. The only way currently to test for it is through an invasive laparoscopic procedure, which comes with risks like internal bleeding, infections and hernia.

Called DotEndo the new DotLab test eliminates that risk with a simple diagnostic test. “The rationale for using our test is to test as early as possible and also to use it non-invasively,” Bowerman told TechCrunch.

The CEO was also quick to point out DotEndo is not a genetic test, as there are plenty of tests out on the market helping women discover possible genetic markers around fertility. Rather, it’s a physician-ordered diagnostic test you would take through a lab to find out if you have this specific disease.

“The revolutionary technology behind DotLab’s endometriosis test could improve the lives of the hundreds of millions of women affected by this debilitating disease which has been under-researched and deprioritized for too long,” Bowerman said in a statement.

While there has been some innovation in the space lately — U.S. regulators just approved a new pill to treat endometriosis pain — Bowerman is right in that we definitely still have a long way to go in diagnosing and curing the disease and that will take a lot more capital from investors in the future.

Meanwhile, the next step for DotLab will be to get its test into the hands of physicians, with the hope they recommend DotEndo right off the bat to patients exhibiting symptoms.


Source: TechCrunch

Tags: in Uncategorized
Banner
Related Posts

This is the next-gen lionfish vacuuming robot

March 13, 2019

March 13, 2019

Roboticists have the strangest pet projects. For Colin Angle, it’s vacuuming up lionfish. The iRobot CEO is also the cofounder...

Apple partners with Aetna to launch health app leveraging Apple Watch data

January 29, 2019

January 29, 2019

In its clearest move yet to woo the healthcare industry, Apple has collaborated with the health insurance provider Aetna to...

Xbox One does away with discs in new $249 All-Digital Edition

April 16, 2019

April 16, 2019

Discs! What are they good for? Well, if they’re nice if you don’t want to be tied to an online-only...

Food delivery startup Dahmakan eats up $5M for expansion in Southeast Asia

May 22, 2019

May 22, 2019

It’s harvest season for Southeast Asia’s full-stack food delivery startups. Following on from Singapore’s Grain raising $10 million, so Malaysia-based...

Decolonization and intersectionality in tech, with Chanda Prescod-Weinstein

May 8, 2019

May 8, 2019

Chanda Prescod-Weinstein is Assistant Professor of Physics and Astronomy and a Core Faculty Member in Women’s Studies at the University...

Startups Weekly: Why Lyft’s $2.2B IPO wasn’t “crazy land” or “nuts”

March 30, 2019

March 30, 2019

Lyft completed its long-awaited IPO this week, trading 21 percent higher Friday than its initial offering price of $72 per...

Zimbabwe’s government faces off against its tech community over internet restrictions

January 24, 2019

January 24, 2019

Jake Bright Contributor Jake Bright is a writer and author in New York City. He is co-author of The Next...

Yes, Americans can opt-out of airport facial recognition. Here’s how

May 13, 2019

May 13, 2019

Whether you like it or not, facial recognition tech to check in for your flight will soon be coming to...

Qualcomm announces a new robotics development platform

February 25, 2019

February 25, 2019

Robotics have long been a bit of a white whale for Qualcomm. The burgeoning field is a pretty logical next...

George R.R. Martin’s Elden Ring RPG is official

June 9, 2019

June 9, 2019

Among the more eagerly anticipated titles of this year’s E3, Elden Ring leaked out just a few days ago. The...

Panic’s Playmate is a pint-sized gaming machine with a ‘season’ of 12 intriguing titles

May 22, 2019

May 22, 2019

Tired of your smartphone games, and don’t want to take the Switch with you on the train today? Panic, renowned...

Huawei is shipping a lot more phones in spite of it all

July 30, 2019

July 30, 2019

There are a lot reasons to assume Huawei’s numbers would be on the decline. Even without getting caught smack in...

IEX’s Katsuyama is no flash in the pan

September 17, 2019

September 17, 2019

When you watch a commercial for one of the major stock exchanges, you are welcomed into a world of fast-moving,...

Google Assistant gets more personalized through a new ‘Picks for You’ feature

May 7, 2019

May 7, 2019

In addition to Google’s plan to bring a more powerful, next-generation Google Assistant to Pixel phones, the company also introduced...

GitHub gets a package registry

May 10, 2019

May 10, 2019

GitHub today announced the launch of a limited beta of the GitHub Package Registry, its new package management service that...

Comments
Leave a Reply

Your email address will not be published. Required fields are marked *